Bionity.COM Newsletter No. 26/2010, 07/07/2010

New Products and Services

> more

Qualitative and quantitative answers at your benchtop
Introducing Xevo G2 QTof from Waters.
Powered by QuanTof technology, the world's most advanced oa-Tof technology, Xevo G2 QTof provides the highest quality and most comprehensive information...

http://www.bionity.com/products/e/119514/

Request information

Vertical pre-cast gels for the electrophoresis lab
anamed Elektrophorese GmbH Recently Launched a New Precastgel-Family.
Called VarioGelR represents a new pH-neutral Polyacrylamid - Gel for vertical slab-gel Electrophoresis, Made in Germany, and very attractive in price/performance....

http://www.bionity.com/products/e/28182/

Request information

Sequip - Sensor & Equipment - Solutions for your particle measurement
Insitu PAT Sensor Systems - Particle and Droplet Size and shape in original concentration
The insitu PAT Sensor determines particle size and shape of your particle systems continuously in situ under process conditions and in lab. You can increase your product quality by continuous quality control over 24 hours. PAT-Sensors measure emulsion, suspension, dispersphased, biocells, powder, granules and aerosols in original concentration...

http://www.bionity.com/products/e/99205/

Request information

Mikrochip Elektrophoresis System for DNA/RNA Analysis
This next-generation microchip electrophoresis system will bring about revolutionary changes in life science laboratories.
The full automated electrophoresis system MultiNA from Shimadzu quickly and easily performs DNA and RNA nucleic acid size confirmation and quantitation. This System uses microchip technology to conduct fully automated high-speed electrophoresis separation and fluorescence detection to perform high-sensitivity analysis...

http://www.bionity.com/products/e/87611/

Request information

Biotech News

> more

Latest News from Biotechnology and Pharma from 06/30/2010 to 07/06/2010

Diagnostic blood test can identify rare lung disease
07/06/2010 - Researchers at the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center have found that a certain blood test can successfully identify lymphangioleiomyomatosis (LAM) in some...
http://www.bionity.com/news/e/119742/

Lilly to Acquire Alnara Pharmaceuticals
Alnara's Pancreatic Enzyme Replacement Therapy, Liprotamase, Currently Under FDA Review
07/06/2010 - Eli Lilly and Company and Alnara Pharmaceuticals, Inc. announced they have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing pro...
http://www.bionity.com/news/e/119712/

Sartorius expands portfolio for process analytics
Alliance with Berlin-based technology company Schmidt + Haensch in the field of refractometry
07/06/2010 - Sartorius has extended its portfolio of instruments for laboratory and process analytics. Sartorius will collaborate with the measurement technology firm Schmidt + Haensch, and add the latter’s refrac...
http://www.bionity.com/news/e/119731/

Ablynx secures €1.5 million in grants
07/06/2010 - Ablynx announced that it has been awarded a grant worth €1.1 million by the Flemish agency for Innovation by Science and Technology (IWT) and a second grant worth €0.4 million from the Portuguese gove...
http://www.bionity.com/news/e/119739/

First step to new therapy for chronic bowel disease
07/06/2010 - Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University (UGent) have discovered that A20 protein plays an important protective role in diseases associated with chron...
http://www.bionity.com/news/e/119740/

Two Hutchinson Center researchers receive prestigious awards from Damon Runyon Cancer Research Foundation
Drs. Brian Till and Colleen Delaney will use the awards for immunotherapy research
07/05/2010 - Two Fred Hutchinson Cancer Research Center researchers who study immunotherapy have received prestigious awards from the Damon Runyon Cancer Research Foundation.
Brian Till, M.D., a research assoc...
http://www.bionity.com/news/e/119711/

Biocitech welcomes new researchers from Pharma Omnium International
07/05/2010 - Biocitech announces the amalgamation on its campus of the anti-infective research teams of Pharma Omnium International, a French pharmaceutical company specialized in research into anti-infectives. ...
http://www.bionity.com/news/e/119705/

AiCuris’ novel resistance breaking HIV compound AIC292 in phase I
07/05/2010 - AiCuris announced that its resistance-breaking NNRTI (Non-Nucleosidic Reverse Transcriptase Inhibitor) for HIV has entered human phase I clinical trials.
Following oral administration the compound ...
http://www.bionity.com/news/e/119664/

Oxford Biomedica and VIB-K.U. Leuven annouce collaborative research project funded by the Motor Neurone Disease Association
07/05/2010 - Oxford BioMedica, VIB and the UK Motor Neurone Disease Association (MND Association) announced the award by MND Association of a research grant to support the further preclinical evaluation of MoNuDin...
http://www.bionity.com/news/e/119671/

Benoît Battistelli takes over as President of the European Patent Office
07/05/2010 - Benoît Battistelli took up office as President of the European Patent Office (EPO). A French national, he succeeds Alison Brimelow of the UK, who has headed the EPO since July 2007. Mr Battistelli was...
http://www.bionity.com/news/e/119668/

The last checkpoint to T cell fate
07/02/2010 - A research team in Japan has linked a developmental checkpoint in the differentiation of hematopoietic progenitors into specific T cell lineages to the activity of a single gene encoding a transcripti...
http://www.bionity.com/news/e/119658/

Sanofi-aventis to acquire TargeGen Inc.
Development of oral potent oncology medicines for the treatment of hematological malignancies
07/02/2010 - Sanofi-aventis announced that it has signed an agreement for the acquisition of TargeGen Inc., a privately held US biopharmaceutical company developing small molecule kinase inhibitors for the treatm...
http://www.bionity.com/news/e/119628/

Evotec Starts Phase II Clinical Studies in Treatment-Resistant Depression
07/02/2010 - Evotec AG announced the start of the proof-of-concept Phase II study in treatment-resistant depression with its NR2B subtype selective NMDA receptor antagonist EVT 101. This clinical development is pa...
http://www.bionity.com/news/e/119660/

Servier and Galapagos initiate strategic alliance in osteoarthritis
07/02/2010 - Servier and Galapagos NV announced that they have entered into a multi-year strategic alliance to develop new therapies in osteoarthritis (OA).
The alliance between Servier and Galapagos builds o...
http://www.bionity.com/news/e/119661/

BioTek Announces New Managing Director of Europe
07/02/2010 - BioTek Instruments, Inc. welcomes Dr. Dirk Frese to the company as Managing Director, Europe, effective immediately. In this newly created position, Dr. Frese is responsible for business integration a...
http://www.bionity.com/news/e/118978/

DSM announces breakthrough in technology for second generation biofuels
07/01/2010 - Royal DSM N.V. announced a major breakthrough in the technology to produce second generation biofuels. This breakthrough will help second generation biofuels to become more cost effective and to becom...
http://www.bionity.com/news/e/119623/

Scientists Find Direct Line From Development to Growth
07/01/2010 - It may seem intuitive that growth and development somehow go together so that plants and animals end up with the right number of cells in all the right places. But it is only now that scientists at th...
http://www.bionity.com/news/e/119482/

Aeterna Zentaris Receives Positive Scientific Advice for its Phase 3 Trial with Perifosine in Colorectal Cancer
07/01/2010 - Aeterna Zentaris Inc. announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lea...
http://www.bionity.com/news/e/119551/

DEINOVE partners with VTT Technical
07/01/2010 - DEINOVE announced a major partnership agreement with VTT Technical Research Centre of Finland.
"We are delighted to welcome VTT's talented scientists onboard the DEINOL project. VTT is the largest...
http://www.bionity.com/news/e/119624/

Astellas Pharma Canada Appoints New President
07/01/2010 - Astellas Pharma Canada, Inc. announced that Michael Tremblay has been appointed president of the Canadian subsidiary of Astellas Pharma Inc. His predecessor, Fumiaki Sakurai, will return to Japan to ...
http://www.bionity.com/news/e/119552/

Carbon nanotubes form ultrasensitive biosensor to detect proteins
06/30/2010 - A cluster of carbon nanotubes coated with a thin layer of protein-recognizing polymer form a biosensor capable of using electrochemical signals to detect minute amounts of proteins, which could provid...
http://www.bionity.com/news/e/119510/

Agriculture and Bio-Based Industries to Generate $230 Billion and Create More than 800,000 Jobs
06/30/2010 - During a keynote address at the BIO World Congress conference, Steen Riisgaard, CEO of Novozymes, unveiled a new report by the World Economic Forum (WEF) which concludes that converting biomass into f...
http://www.bionity.com/news/e/119540/

PharmaNeuroBoost’s lead product in major depression receives IND approval from FDA
06/30/2010 - PharmaNeuroBoost NV (PNB) reported that the U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) application for PNB01. PNB01 is a proprietary owned, fixed dose combinat...
http://www.bionity.com/news/e/119492/

caprotec bioanalytics Announces the Successful Completion of a Collaborative Research Project With Roche
06/30/2010 - caprotec bioanalytics GmbH announced that it has successfully completed a research collaboration with F. Hoffmann-La Roche, Basel, Switzerland. Under the collaboration research agreement, caprotec use...
http://www.bionity.com/news/e/119538/

Fred Walder joins Fluidigm as Chief Business Officer
06/30/2010 - Fluidigm Corporation announced Fred Walder has joined the company at its new Chief Business Officer. Walder joins Fluidigm after a long and celebrated career at a Fortune 500 company, Thermo Fisher Sc...
http://www.bionity.com/news/e/119539/

Catalogues and Brochures

> more

Novodirect General Catalogue
This catalogue features a wide selection of more than 35,000 products for industry and research. Please take notice of our sales...

http://www.bionity.com/catalogs/e/55408/

Order catalogue

Events

> more

Events, Workshops and Training Courses